# Efficacy and Safety of Uronext® in Women With Cystitis

> **NCT05945667** · NA · COMPLETED · sponsor: **PharmaLinea Ltd.** · enrollment: 111 (actual)

## Conditions studied

- Cystitis

## Interventions

- **DRUG:** Monural
- **DIETARY_SUPPLEMENT:** UroNext

## Key facts

- **NCT ID:** NCT05945667
- **Lead sponsor:** PharmaLinea Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-07
- **Primary completion:** 2021-12-21
- **Final completion:** 2022-02-28
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945667, "Efficacy and Safety of Uronext® in Women With Cystitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05945667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*